Shenglan Li

1.2k total citations · 1 hit paper
53 papers, 818 citations indexed

About

Shenglan Li is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Shenglan Li has authored 53 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Surgery. Recurrent topics in Shenglan Li's work include Glioma Diagnosis and Treatment (6 papers), Immune cells in cancer (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Shenglan Li is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Immune cells in cancer (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Shenglan Li collaborates with scholars based in China, United Kingdom and United States. Shenglan Li's co-authors include Chen Shen, Xiaopeng Wang, Zhongju Liao, Huixiang Yang, Jinglei Li, Lijian Tao, Sha Tu, Zhangzhe Peng, Ying He and Wei An and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shenglan Li

41 papers receiving 803 citations

Hit Papers

Facilitating or inhibiting? Spatial effects of the digita... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Facilitating or inhibiting? Spatial effects of the digital economy affecting urban green technology innovation
    2023 113 citations Shenglan Li et al. profile →

Peers

Shenglan Li
Wenwen Wang China
Qing Ding China
Yunfang Li China
Lina Xu China
Sha Liu China
Fangming Xu China
Wenke Wang China
Lei Du China
Wenwen Wang China
Shenglan Li
Citations per year, relative to Shenglan Li Shenglan Li (= 1×) peers Wenwen Wang

Countries citing papers authored by Shenglan Li

Since Specialization
Citations

This map shows the geographic impact of Shenglan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Li more than expected).

Fields of papers citing papers by Shenglan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Li. The network helps show where Shenglan Li may publish in the future.

Co-authorship network of co-authors of Shenglan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Li. A scholar is included among the top collaborators of Shenglan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Li. Shenglan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Shenglan, et al.. (2025). Re‐Innovation in Clinical Trial Designs Based on Precision Therapy. PubMed. 4(5). e70028–e70028.
3.
Zhang, Chi, Jinhui Zhou, Furui Tan, et al.. (2025). Research Progress on Thermoelectric Properties of Doped SnSe Thin Films. Coatings. 15(9). 1041–1041.
4.
Chen, Jie, et al.. (2025). Research Progress on Narrow-Linewidth Broadband Tunable External Cavity Diode Lasers. Coatings. 15(9). 1035–1035.
5.
Dong, Longjun, et al.. (2025). Computational Analysis of Fault-Slip Induced Strainburst Using Strain Energy Density. Geotechnical and Geological Engineering. 43(2). 2 indexed citations
6.
7.
Gu, Lei, et al.. (2024). Mefunidone ameliorates acute liver failure in mice by inhibiting MKK4-JNK pathway. Biochemical Pharmacology. 225. 116267–116267. 6 indexed citations
8.
9.
Li, Shenglan, et al.. (2024). Correlation between sarcopenia and esophageal cancer: a narrative review. World Journal of Surgical Oncology. 22(1). 27–27. 10 indexed citations
10.
Kang, Xun, Bo Jiang, Feng Chen, et al.. (2023). Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis via an ommaya reservoir. Frontiers in Oncology. 12. 1060575–1060575.
11.
Li, Shenglan, Rui Yao, Yong Zhou, et al.. (2023). Unsupervised RGB-T object tracking with attentional multi-modal feature fusion. Multimedia Tools and Applications. 82(15). 23595–23613. 4 indexed citations
12.
Kang, Zhuang, Shenglan Li, Yi Lin, et al.. (2023). A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors. Investigational New Drugs. 41(2). 296–305. 4 indexed citations
13.
Li, Shenglan, et al.. (2023). Does CSR Information Disclosure Improve Investment Efficiency? The Moderating Role of Analyst Attention. Sustainability. 15(16). 12310–12310. 3 indexed citations
14.
Li, Shenglan, et al.. (2023). The influence of biochar supported nano‐zero valent iron on the anaerobic digestion of sulfate wastewater. Environmental Progress & Sustainable Energy. 42(5). 1 indexed citations
15.
Li, Shenglan, Yan Zhang, Rong Lü, et al.. (2023). Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle/Syk/NF-κB signaling. Kidney International. 104(2). 305–323. 40 indexed citations
16.
17.
Li, Song, Yuqin Deng, Hong‐Li Hua, et al.. (2022). Deep learning for locally advanced nasopharyngeal carcinoma prognostication based on pre- and post-treatment MRI. Computer Methods and Programs in Biomedicine. 219. 106785–106785. 11 indexed citations
18.
Wang, Tao, Xi Yu, Jian Lin, et al.. (2019). Adipose-Derived Stem Cells Inhibited the Proliferation of Bladder Tumor Cells by S Phase Arrest and Wnt/β-Catenin Pathway. Cellular Reprogramming. 21(6). 331–338. 12 indexed citations
19.
Fang, Yi, et al.. (2017). The Study on the Integration Degree in China's Carbon Market: Analysis Based on the Sample of Pilot Provinces and Cities. Cai-jing yanjiu. 43(2). 84–96. 2 indexed citations
20.
Li, Shenglan. (2004). A Study of the Development Mode of External-oriented Urbanization. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenwen Wang Breakdown of academic impact, for papers by Qing Ding Breakdown of academic impact, for papers by Yunfang Li Breakdown of academic impact, for papers by Lina Xu Breakdown of academic impact, for papers by Sha Liu Breakdown of academic impact, for papers by Fangming Xu Breakdown of academic impact, for papers by Wenke Wang Breakdown of academic impact, for papers by Lei Du
Rankless by CCL
2026